CUANDO LA FUNCION HEPATICA ESTA PRESERVADA, LOS PACIENTES CON LINFOMA DIFUSO DE GRANDES CELULAS B E INFECCION POR VHC PUEDEN TOLERAR EL TRATAMIENTO
Columnista Experto de SIIC Carlo Visco
en colaboración con
Fecha de aprobación: 15 de septiembre, 2008
Primera edición en siicsalud:
20 de mayo, 2009
Sección Artículos originales,
subsección
Expertos de Iberoamérica,
página
/des/expertocompleto.php/98987
Especialidad principal:
Hematología
Oncología
Especialidades relacionadas:
Bioquímica,Diagnóstico por Laboratorio,Gastroenterología,Infectología,Medicina Interna,
Tecchio C, Nadali G, Scapini P, Bonetto C, Visco C, Tamassia N, Vassilakopoulos TP, Pangalis GA, Calzetti F, et al. High serum levels of B-lymphocyte stimulator are associated with clinical-pathological features and outcome in classical Hodgkin lymphoma, Br J Haematol 137:553-559, 2007
Visco C, Giaretta I, Ruggeri M, Madeo D, Tosetto A, Rodeghiero F. Un-mutated IgVH in chronic lymphocytic leukemia is associated with a higher risk of immune thrombocytopenia, Leukemia 21:1092-1093, 2007
Visco C, Nadali G, Vassilakopoulos TP, Bonfante V, Viviani S, Alessandro M, et al. Very high levels of soluble CD30 recognize patients with classical Hodgkin's lymphoma retaining a very poor prognosis, Eur J Hematol 77:387-394, 2006
Visco C, Arcaini L, Brusamolino E, Burcheri S, Ambrosetti A, Merli M, Bonoldi E. Distinctive natural history in hepatitis C virus positive diffuse large B-cell lymphoma: Analysis of 156 patients from northern Italy., Annals of Oncology 17:1434-1440, 2006
Visco C, Canal F, Parolini C, Andreoli A, Ambrosetti A, Krampera M, Lestani M, Pizzolo G, Chilosi M. The impact of P53 and P21waf1 expression on the survival of patients with the germinal center phenotype of diffuse large B-cell lymphoma, Haematologica 91:687-690, 2006
Visco C, Vassilakopoulos T, Kliche KO, Nadali G, Viviani S, Bonfante V., Medeiros LJ, Notti P, Rassidakis GZ, Peethambaram P, Wilder R, Witzig T, Gianni M, Bonadonna G, et al. Elevated serum levels of IL-10 are associated with inferior progression-free survival in patients with Hodgkin's disease treated with radiotherapy, Leukemia & Lymphoma 45:2085-2092, 2004
Krampera M, Venturini F, Benedetti F, Oliani A, Carolei S, Visco C, Aqel H, Pizzolo G, Scroccaro G. Computer-based drug management in a bone marrow transplant unit: a suitable tool for multiple prescriptions even in critical conditions, British Journal of Hematology 125:50-58, 2004
Visco C, Medeiros LJ, Jones D, Smith T, Rodriguez MA, McLaughlin P, Romaguera J, Cabanillas F, Sarris AH. Primary cutaneous non Hodgkin's lymphoma with aggressive histology: inferior outcome is associated with peripheral T-cell type and elevated lactate dehydrogenase, but not extent of cutaneous involvement, Annals of Oncology 13:1290-1299, 2002
Visco C, Medeiros LJ, Mesina OM, Rodriguez MA, Hagemeister FB, McLaughlin P, Romaguera JE, Cabanillas F, Sarris AH. Non-Hodgkin's lymphoma affecting the testis: Is it curable with doxorubicin-based therapy?, Clinical Lymphoma 2:40-46, 2001
Carlo Visco
Dirección profesional:
Via Rodolfi 37 - 36100, Vicenza, Italia
